Literature DB >> 19019940

Vision screening in children by Plusoptix Vision Screener compared with gold-standard orthoptic assessment.

A H Dahlmann-Noor1, K Vrotsou, V Kostakis, J Brown, J Heath, A Iron, S McGill, A J Vivian.   

Abstract

BACKGROUND/AIMS: To evaluate a new autorefractor, the Plusoptix Vision Screener (PVS), as a screening tool to detect risk factors for amblyopia by comparing it with gold-standard orthoptic vision screening in children.
METHODS: Community-based screening study including 288 children age 4-7 years who were screened with the PVS and by orthoptic assessment (distance acuity, cover test, extraocular movements, 20 PD prism test, Lang stereotest). Follow-up comprehensive eye examination of screening-positive children included manual cycloplegic retinoscopy.
RESULTS: Testability was high for both methods. Orthoptic screening identified 36 children with reduced vision and/or factors associated with amblyopia (referral rate 12.5%). The PVS identified 16 children with potential vision problems (referral rate 5.6%), indicating only moderate sensitivity (44%; 95% CI 27.9 to 61.9%), but high specificity (100%; 95% CI 98.5 to 100%) to detect factors associated with amblyopia. The PVS underestimated visually significant refractive errors.
CONCLUSIONS: Use of the PVS as single screening test in young children may miss a significant number of children with amblyopia or amblyogenic risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 19019940     DOI: 10.1136/bjo.2008.138115

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Receding and disparity cues aid relaxation of accommodation.

Authors:  Anna M Horwood; Patricia M Riddell
Journal:  Optom Vis Sci       Date:  2009-11       Impact factor: 1.973

2.  Comparison of the Retinomax hand-held autorefractor versus table-top autorefractor and retinoscopy.

Authors:  Ibrahim Tuncer; Mehmet Ozgur Zengin; Eyyup Karahan
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

3.  Photoscreeners in the pediatric eye office: compared testability and refractions on high-risk children.

Authors:  Mae Millicent W Peterseim; Carrie E Papa; M Edward Wilson; Edward W Cheeseman; Bethany J Wolf; Jennifer D Davidson; Rupal H Trivedi
Journal:  Am J Ophthalmol       Date:  2014-08-01       Impact factor: 5.258

Review 4.  Tests for detecting strabismus in children aged 1 to 6 years in the community.

Authors:  Sarah Hull; Vijay Tailor; Sara Balduzzi; Jugnoo Rahi; Christine Schmucker; Gianni Virgili; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

5.  Photorefraction estimates of refractive power varies with the ethnic origin of human eyes.

Authors:  N Geetha Sravani; Vinay Kumar Nilagiri; Shrikant R Bharadwaj
Journal:  Sci Rep       Date:  2015-01-23       Impact factor: 4.379

6.  Performance of the Plusoptix A09 photoscreener in detecting amblyopia risk factors in Chinese children attending an eye clinic.

Authors:  Xiao-Ran Yan; Wan-Zhen Jiao; Zhi-Wei Li; Wen-Wen Xu; Feng-Jiao Li; Li-Hua Wang
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

7.  Vision screening for children 36 to <72 months: recommended practices.

Authors:  Susan A Cotter; Lynn A Cyert; Joseph M Miller; Graham E Quinn
Journal:  Optom Vis Sci       Date:  2015-01       Impact factor: 1.973

8.  Accuracy of PlusOptix A09 distance refraction in pediatric myopia and hyperopia.

Authors:  Arnaud Payerols; Claudie Eliaou; Véronique Trezeguet; Max Villain; Vincent Daien
Journal:  BMC Ophthalmol       Date:  2016-06-01       Impact factor: 2.209

9.  Calibration of the PlusOptix PowerRef 3 with change in viewing distance, adult age and refractive error.

Authors:  Saeideh Ghahghaei; Olivia Reed; T Rowan Candy; Arvind Chandna
Journal:  Ophthalmic Physiol Opt       Date:  2019-07       Impact factor: 3.117

10.  Pediatric vision screening using the plusoptiX A12C photoscreener in Chinese preschool children aged 3 to 4 years.

Authors:  Dan Huang; Xuejuan Chen; Xiaohan Zhang; Yue Wang; Hui Zhu; Hui Ding; Jing Bai; Ji Chen; Zhujun Fu; Zijin Wang; Hu Liu
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.